February 14, 2014 Actelion announced today that SwissMedic has approved Opsumit® (macitentan) for PAH patients within Switzerland. Opsumit is indicated for the long-term treatment of …
February 14, 2014 Actelion announced today that SwissMedic has approved Opsumit® (macitentan) for PAH patients within Switzerland. Opsumit is indicated for the long-term treatment of …